KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-cash Items (2016 - 2025)

TherapeuticsMD's Non-cash Items history spans 15 years, with the latest figure at $987000.0 for Q4 2025.

  • For Q4 2025, Non-cash Items rose 1117.53% year-over-year to $987000.0; the TTM value through Dec 2025 reached -$1.2 million, up 86.86%, while the annual FY2025 figure was $105000.0, 84.21% up from the prior year.
  • Non-cash Items reached $987000.0 in Q4 2025 per TXMD's latest filing, up from $51000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $22.7 million in Q3 2021 to a low of -$18.2 million in Q4 2022.
  • Average Non-cash Items over 5 years is -$513312.1, with a median of $51000.0 recorded in 2025.
  • Peak YoY movement for Non-cash Items: tumbled 2492.71% in 2023, then surged 1907042.86% in 2025.
  • A 5-year view of Non-cash Items shows it stood at -$2.1 million in 2021, then crashed by 748.09% to -$18.2 million in 2022, then soared by 81.23% to -$3.4 million in 2023, then skyrocketed by 97.16% to -$97000.0 in 2024, then soared by 1117.53% to $987000.0 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Non-cash Items are $987000.0 (Q4 2025), $51000.0 (Q3 2025), and $51000.0 (Q2 2025).